Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Several late-stage pipeline products have the potential to address some of these unmet needs
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
The Theme of the event was 'Building One Health Together – Improving Health Equity'
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
India's strategy against Covid was more effective than any other countries in the world
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Bourgoin early development hub broadens offerings for oral solid dose formulations
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Subscribe To Our Newsletter & Stay Updated
